Insight

Jun 12, 2024, 11:04

Iván R. González on a paper by Marjorie E. Zettler

Iván R. González, Medical Oncologist at Comprehensive Oncology Center, Hospital Ángeles Puebla, shared a post on X:

“Optimizing cancer therapy dosages is essential!

Targeted therapies have slashed cancer mortality and set a new standard, but traditional dosing methods lag behind. The FDA’s Project Optimus and new guidelines aim to fix this. Reshaping pre-approval dosing and continuous research will maximize patient benefits and minimize avoidable toxicity.

Future incentives for post-market dose optimization could be a game-changer.”

Read further
Source: Iván R. González/X

cancer cancer therapy Comprehensive Oncology Center dose optimization FDA Hospital Ángeles Puebla Iván R. González Marjorie E. Zettler OncoDaily Oncology Project Optimus targeted therapy

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity